04-Mar-2021

At 20.32% CAGR Aptamers Market To Reach US$ 14,118.56 Million By 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global aptameters market, by product type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers) and Peptide Aptamers), by application (Diagnostics, Therapeutics, and Research and Development), by end-user (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was evaluated at US$ 3626.13 million in 2019, and is expected to witness a resilient 18.5% CAGR during the forecast period (2019-2027).

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/774

Increasing R&D programs carried out by various biopharmaceutical companies and research institutes are said to be propelling the global aptameters market growth. For instance, in 2016, the Institute of Bioengineering and Nanotechnology (IBN), Singapore, invented an efficient DNA aptameter technology for the diagnosis and treatment of cancer, along with several infectious diseases, such as dengue and malaria. In April 2019, Aptamer Therapeutics Ltd. announced its partnership deal with Dan Wiseman and the Oglesby Leukemia Research Program, which was being conducted at the University of Manchester and Cancer Research UK, for the development of aptameters as therapeutic agents for the treatment of Chronic Myelomonocytic Leukemia (CMML) and other myeloid malignancies. Furthermroe, the University of Minnesota launched an exclusive aptameter technology for radiation therapy in July 2019, for treating brain tumor patients using the advanced radiosurgery technology.

Introduction of next-generation equipment, coupled with rising investments by various biotechnological and pharmaceutical companies, majorly contributes to the growth of the global aptamers market. In addition, the growing number of academic research laboratories, as well as increasing number of products under clinical investigation, have triggered the market penetration of aptameters and boosted their demand across the globe.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/774

Key Takeaways of the Global Aptamers Market:

Among the various product types, the nucleic acid aptamers segment is foreseen to garner a major revenue share in the global aptamers market over the projected timeframe.
The most prominent players operating in the global aptamers market include Elekta AB, Varian Medical Systems Inc., Huiheng Medical Inc., Cyber Medical Corporation Limited, Masep Infini Global Inc., ET Medical Group, Nordion Inc., Hokai, and GE Healthcare.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/aptamers-market-to-surge-past-us-10407-million-by-2025-due-to-widened-application-area-342

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Type
  - Market Snippet, By Application
  - Market Snippet, By End User
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- PEST Analysis
Global Aptamers Market, By Type, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Nucleic Acid Aptamers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
    - DNA-Based Aptamers
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    - RNA-Based Aptamers
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    - XNA-Based Aptamers
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Peptide Aptamers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Aptamers Market, By Application, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Diagnostics
- Therapeutics
- Research and Development
Global Aptamers Market, By End User, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutions
- Contract Research Organization
Global Aptamers Market, By Region, 2019 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2026
  - Regional Trends
- North America
  - Market Size and Forecast, By Type, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Type, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Africa
  - Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country/Region, 2016 – 2027 , (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
- Middle East
  - Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
    - GCC Countries
    - Israel
    - Rest of Middle East
Competitive Landscape
- Company Profiles
  - Ophthotech Corporation
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Aptamer Sciences, Inc.
  - Novartis AG
  - SomaLogic, Inc.
  - NeoNeuro SAS
  - Aptagen, LLC
  - Aptus Biotech S.L.
  - AM Biotechnologies, LLC
  - Base Pair Biotechnologies
  - Vivonics Inc.
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 04-Mar-2021